title: Grenz ray therapy in the new millennium: still a valid treatment option?
abstract: Grenz ray therapy has declined in the United States during the past several decades with respect to availability, use, and resident training. However, it remains a simple, affordable, and effective option for managing several refractory dermatoses, especially psoriasis, hand eczema, and allergic contact dermatitis. Though high-dose grenz irradiation has been associated with the development of nonmelanoma skin cancers, grenz ray therapy is considered a safe treatment modality when administered according to the guidelines recommended herein. We review the value of grenz irradiation in contemporary dermatology.
authors.affiliation: The Johns Hopkins University School of Medicine, USA.
authors.forename: Jennifer A
authors.initials: JA
authors.lastname: Warner
authors.forename: Ponciano D
authors.initials: PD
authors.lastname: Cruz
mesh_terms: D002986:Clinical Trials as Topic; D003880:Dermatology / Q000639:trends; D004485:Eczema / Q000532:radiotherapy; D049673:History, 20th Century; D006801:Humans; D009784:Occupational Diseases / Q000209:etiology; D017410:Practice Guidelines as Topic; D011565:Psoriasis / Q000532:radiotherapy; D012871:Skin Diseases / Q000532:radiotherapy*; D012878:Skin Neoplasms / Q000209:etiology*; D014964:X-Ray Therapy / Q000009:adverse effects / Q000266:history / Q000379:methods* / Q000706:statistics & numerical data